Cell News and Research

RSS

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.

20 Apr 2013

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.

20 Apr 2013

Shc plays key role in activating and controlling Erk

A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive, a team led by scientists from The University of Texas MD Anderson Cancer Center reports this week in Nature Structural Molecular Biology.

20 Apr 2013

Study identifies seven new genetic regions associated with pulmonary fibrosis

A new genome-wide association study of more than 6,000 people has identified seven new genetic regions associated with pulmonary fibrosis. In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease.

20 Apr 2013

Vision expo to offer rehabilitation information to blind and visually impaired patients

A daylong vision expo will be held Saturday, April 20 at the University of Houston (UH), offering information on rehabilitation and resources for the blind and visually impaired to live independent and productive lives.

19 Apr 2013

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment for these patients.

19 Apr 2013

Combination therapies may advance treatment for anaplastic thyroid cancer

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.

19 Apr 2013

Three MGH projects named among Top 10 Clinical Research Achievements of 2012

Three projects led by Massachusetts General Hospital investigators have been named among the Clinical Research Forum's Top 10 Clinical Research Achievements of 2012.

19 Apr 2013

PKC supplies Nano-Impedance Biosensor for detecting VEGF-165

Pharmaco-Kinesis Corporation, developer of a pre-commercialized smart implantable pump for localized cancer-fighting drug delivery, today announced its first commercialized offering, the first-generation Nano-Impedance Biosensor.

19 Apr 2013

HUGO recognizes Dr. Patrick Tan for research on genomic profiles of Asian cancers

Dr Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organisation.

19 Apr 2013

Good news: Public support increasing for living, deceased organ donation

Good news for anyone needing a transplant; a new Mayo Clinic survey shows that the public's support for both living and deceased organ donation is increasing.

19 Apr 2013

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

Patients from ethnic minority and mixed-racial backgrounds are less likely to receive a lifesaving bone marrow transplant than Caucasian patients with the same disease due to lack of matching donors, according to the National Marrow Donor Program.

19 Apr 2013

GBM brain cancer patient treated with DCVax-L celebrates 10th anniversary of cancer-free survival

Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that Brad Silver, an All American swimming and water polo athlete who was diagnosed with Glioblastoma multiforme brain cancer in late 2002, and was treated with DCVax-L in March of 2003, just celebrated the 10th anniversary of his continued cancer-free survival.

19 Apr 2013

SironRX completes enrollment in Cohort 1 to study JVS-100 for wound healing, scar prevention

SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.

19 Apr 2013

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.

19 Apr 2013

Research shows infants experience automatic calming reaction when carried by their mothers

There is a very good reason mothers often carry their crying babies, pacing the floor, to help them calm down. New research published in the Cell Press journal Current Biology on April 18 shows that infants experience an automatic calming reaction upon being carried, whether they are mouse or human babies.

19 Apr 2013

Cell News and Research

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Shc plays key role in activating and controlling Erk

Study identifies seven new genetic regions associated with pulmonary fibrosis

Vision expo to offer rehabilitation information to blind and visually impaired patients

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Combination therapies may advance treatment for anaplastic thyroid cancer

Three MGH projects named among Top 10 Clinical Research Achievements of 2012

PKC supplies Nano-Impedance Biosensor for detecting VEGF-165

HUGO recognizes Dr. Patrick Tan for research on genomic profiles of Asian cancers

Good news: Public support increasing for living, deceased organ donation

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

GBM brain cancer patient treated with DCVax-L celebrates 10th anniversary of cancer-free survival

SironRX completes enrollment in Cohort 1 to study JVS-100 for wound healing, scar prevention

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Research shows infants experience automatic calming reaction when carried by their mothers

Excess glutamate drives schizophrenia in high-risk individuals

Researcher explores new way to deliver therapy to brain metastases from primary breast cancer

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

North American scientists chart new territory in immunity research

How to optimize your cell line development eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics